Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent insights into the mode of action of memantine and ketamine
Jon W. Johnson, Nathan G. Glasgow, Nadezhda V. Povysheva
Current Opinion in Pharmacology (2014) Vol. 20, pp. 54-63
Open Access | Times Cited: 105

Showing 26-50 of 105 citing articles:

Negative Symptoms in Schizophrenia: An Update on Research Assessment and the Current and Upcoming Treatment Landscape
Preetika Govil, Joshua T. Kantrowitz
CNS Drugs (2025)
Closed Access
Ketamine does not rescue plaque load or gap detection in the 5XFAD mouse model of Alzheimer's disease
Anne L. Wright, Aldis P. Weible, Olivia B. Estes, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Mechanisms of NMDA receptor inhibition by vortioxetine – comparison with fluoxetine
Arseniy S. Zhigulin, Oleg I. Barygin
European Journal of Pharmacology (2025), pp. 177460-177460
Closed Access
Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy
Charles F. Zorumski, Peter Nägele, Steven Mennerick, et al.
Frontiers in Psychiatry (2015) Vol. 6
Open Access | Times Cited: 48
7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer’s Disease Treatment
Jan Korábečný, Martin Andrš, Eugenie Nepovimová, et al.
Molecules (2015) Vol. 20, Iss. 12, pp. 22084-22101
Open Access | Times Cited: 42
Multifunctional Analogs of Kynurenic Acid for the Treatment of Alzheimer’s Disease: Synthesis, Pharmacology, and Molecular Modeling Studies
Girdhar Singh Deora, Srinivas Kantham, Stephen Chan, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 12, pp. 2667-2675
Closed Access | Times Cited: 36
Inflammatory mediator-induced modulation of GABAA currents in human sensory neurons
X.-L. Zhang, Kyung‐Yul Lee, Birgit T. Priest, et al.
Neuroscience (2015) Vol. 310, pp. 401-409
Open Access | Times Cited: 35
Dose-response characteristics of intravenous ketamine on dissociative stereotypy, locomotion, sensorimotor gating, and nociception in male Sprague-Dawley rats
Kennett D. Radford, Thomas Y. Park, Bong Hyo Lee, et al.
Pharmacology Biochemistry and Behavior (2016) Vol. 153, pp. 130-140
Open Access | Times Cited: 35
BDNF deficiency and enriched environment treatment affect neurotransmitter gene expression differently across ages
Brittany Dong, Hao Chen, Kazuko Sakata
Journal of Neurochemistry (2020) Vol. 154, Iss. 1, pp. 41-55
Open Access | Times Cited: 27
Tau protein plays a role in the mechanism of cognitive disorders induced by anesthetic drugs
Zheping Chen, Shenghan Wang, Zhaoqian Meng, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 10
Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
Tetsuro Kikuchi
Biomolecules (2020) Vol. 10, Iss. 8, pp. 1134-1134
Open Access | Times Cited: 26
Specific activation of GluN1-N2B NMDA receptors underlies facilitation of cortical spreading depression in a genetic mouse model of migraine with reduced astrocytic glutamate clearance
Giovanna Crivellaro, Angelita Tottene, Marina Consuelo Vitale, et al.
Neurobiology of Disease (2021) Vol. 156, pp. 105419-105419
Open Access | Times Cited: 20
ON or OFF?: Modulating the N-Methyl-D-Aspartate Receptor in Major Depression
Shi Yu Chan, Edward Matthews, Philip W. J. Burnet
Frontiers in Molecular Neuroscience (2017) Vol. 9
Open Access | Times Cited: 25
Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors
Marharyta Kolcheva, Štěpán Kortus, Barbora Hrčka Krausová, et al.
Neuropharmacology (2021) Vol. 189, pp. 108528-108528
Closed Access | Times Cited: 19
Combination of Tramiprosate, Curcumin, and SP600125 Reduces the Neuropathological Phenotype in Familial Alzheimer Disease PSEN1 I416T Cholinergic-like Neurons
Nicolas Gomez-Sequeda, Marlene Jiménez-Del-Río, Carlos Vélez-Pardo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4925-4925
Open Access | Times Cited: 2
Effects of Mg2+ on recovery of NMDA receptors from inhibition by memantine and ketamine reveal properties of a second site
Nathan G. Glasgow, Madeleine R. Wilcox, Jon W. Johnson
Neuropharmacology (2018) Vol. 137, pp. 344-358
Open Access | Times Cited: 22
Memantine and its benefits for cancer, cardiovascular and neurological disorders
Vahid Shafiei‐Irannejad, Samin Abbaszadeh, Paul M.L. Janssen, et al.
European Journal of Pharmacology (2021) Vol. 910, pp. 174455-174455
Closed Access | Times Cited: 17
A Bibliometric Analysis of Research on Ketamine From 2001 to 2020
Huihui Miao, Kang Yu, Danyang Gao, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 11
Inhibition of in vivo [3H]MK-801 binding by NMDA receptor open channel blockers and GluN2B antagonists in rats and mice
Alda Fernandes, Trevor Wojcik, Praveena Baireddy, et al.
European Journal of Pharmacology (2015) Vol. 766, pp. 1-8
Closed Access | Times Cited: 19
Memantine, a Low-Affinity NMDA Receptor Antagonist, Protects against Methylmercury-Induced Cytotoxicity of Rat Primary Cultured Cortical Neurons, Involvement of Ca2+ Dyshomeostasis Antagonism, and Indirect Antioxidation Effects
Wei Liu, Zhaofa Xu, Tianyao Yang, et al.
Molecular Neurobiology (2016) Vol. 54, Iss. 7, pp. 5034-5050
Closed Access | Times Cited: 19
Modulating synaptic NMDA receptors
Kenneth R. Tovar, Gary L. Westbrook
Neuropharmacology (2016) Vol. 112, pp. 29-33
Open Access | Times Cited: 18
Biosensors Show the Pharmacokinetics of S-Ketamine in the Endoplasmic Reticulum
Kallol Bera, Aron Kamajaya, Amol V. Shivange, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 17
Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection
Hélène Blasco, Franck Patin, Christian Andrés, et al.
Expert Opinion on Pharmacotherapy (2016) Vol. 17, Iss. 12, pp. 1669-1682
Closed Access | Times Cited: 16
Glutamate NMDA Receptor Antagonists with Relevance to Schizophrenia: A Review of Zebrafish Behavioral Studies
Ângelo Piato, Radharani Benvenutti, Matheus Gallas‐Lopes, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 3, pp. 494-509
Open Access | Times Cited: 13
Opposing effects of NMDA receptor antagonists on early life stress‐induced aggression in mice
Jacob C. Nordman, Caitlyn J. Bartsch, Zheng Li
Aggressive Behavior (2022) Vol. 48, Iss. 3, pp. 365-373
Open Access | Times Cited: 9

Scroll to top